Fingerprint
Dive into the research topics where Kate Brown is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 2 Article
-
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells, A., Flaherty, K., Brown, K., Inoue, Y., Devaraj, A., Richeldi, L., Moua, T., Crestani, B., Wuyts, W., Stowasser, S., Quaresma, M., Goeldner, R. & investigators, I. T., 4 May 2020, In: The Lancet. Respiratory medicine. 8, 5, p. 453-460Research output: Contribution to journal › Article › peer-review
477 Link opens in a new tab Citations (Scopus) -
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.
Walsh, S., Maher, T., Kolb, M., Poletti, V., Nusser, R., Richeldi, L., Vancheri, C., Wilsher, M., Antoniou, K., Behr, J., Bendstrup, E., Brown, K., Calandriello, L. & Consortium, I. P., 31 Aug 2017, (Published online) In: European Respiratory Journal. 50, 2, p. 1-10Research output: Contribution to journal › Article › peer-review
78 Link opens in a new tab Citations (Scopus)